421 related articles for article (PubMed ID: 26816829)
41. Oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma: a literature review.
Grob G; Rogers D; Pandolfo SD; Vourganti S; Buscarini M; Mehrazin R; Grob BM; Mir MC; Perdonà S; Derweesh IH; Franco A; Cherullo EE; Hemal AK; Autorino R
Transl Androl Urol; 2023 Aug; 12(8):1351-1362. PubMed ID: 37680219
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
43. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
Rink M; Ehdaie B; Cha EK; Green DA; Karakiewicz PI; Babjuk M; Margulis V; Raman JD; Svatek RS; Fajkovic H; Lee RK; Novara G; Hansen J; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Fisch M; Scherr DS; Shariat SF; ;
Eur Urol; 2012 Oct; 62(4):677-84. PubMed ID: 22349570
[TBL] [Abstract][Full Text] [Related]
44. [French ccAFU guidelines - Update 2018-2020: Upper tract urothelial carcinoma].
Rouprêt M; Xylinas E; Colin P; Houédé N; Compérat E; Audenet F; Larré S; Masson-Lecomte A; Pignot G; Brunelle S; Roumiguié M; Neuzillet Y; Méjean A
Prog Urol; 2018 Nov; 28 Suppl 1():R34-R47. PubMed ID: 31610873
[TBL] [Abstract][Full Text] [Related]
45. Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience.
Elawdy MM; Osman Y; Taha DE; Zahran MH; El-Halwagy S; Garba ME; Harraz AM
Arab J Urol; 2017 Sep; 15(3):216-222. PubMed ID: 29071155
[TBL] [Abstract][Full Text] [Related]
46. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
[TBL] [Abstract][Full Text] [Related]
47. Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.
Mbeutcha A; Rouprêt M; Kamat AM; Karakiewicz PI; Lawrentschuk N; Novara G; Raman JD; Seitz C; Xylinas E; Shariat SF
World J Urol; 2017 Mar; 35(3):337-353. PubMed ID: 27101100
[TBL] [Abstract][Full Text] [Related]
48. Narrative review of nephron-sparing surgical management of upper tract urothelial carcinoma: is there a role for distal ureterectomy, segmental ureterectomy, and partial nephrectomy.
Saini S; Deveshwar SP; Hemal AK
Transl Androl Urol; 2024 Jan; 13(1):156-164. PubMed ID: 38404550
[TBL] [Abstract][Full Text] [Related]
49. Neoadjuvant chemotherapy for upper tract urothelial carcinoma.
Kim DK; Cho KS
Transl Cancer Res; 2020 Oct; 9(10):6576-6582. PubMed ID: 35117267
[TBL] [Abstract][Full Text] [Related]
50. Endoscopic exploration directly impacts clinical decision making in the management of patients with suspected upper tract urothelial carcinoma following radical cystectomy.
Aumatell J; Huguet J; Subiela JD; Gaya JM; Faba ÓR; Territo A; Palou J; Breda A
Urol Oncol; 2021 Oct; 39(10):732.e1-732.e8. PubMed ID: 33863619
[TBL] [Abstract][Full Text] [Related]
51. European guidelines on upper tract urothelial carcinomas: 2013 update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester R; Burger M; Cowan N; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF;
Eur Urol; 2013 Jun; 63(6):1059-71. PubMed ID: 23540953
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.
Lughezzani G; Burger M; Margulis V; Matin SF; Novara G; Roupret M; Shariat SF; Wood CG; Zigeuner R
Eur Urol; 2012 Jul; 62(1):100-14. PubMed ID: 22381168
[TBL] [Abstract][Full Text] [Related]
53. Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis.
Guo RQ; Hong P; Xiong GY; Zhang L; Fang D; Li XS; Zhang K; Zhou LQ
BJU Int; 2018 Feb; 121(2):184-193. PubMed ID: 29032580
[TBL] [Abstract][Full Text] [Related]
54. Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.
Zhong W; Zhang L; Ma J; Shao S; Lin R; Li X; Xiong G; Fang D; Zhou L
Onco Targets Ther; 2017; 10():5775-5782. PubMed ID: 29255365
[TBL] [Abstract][Full Text] [Related]
55. [Surgical treatment of upper tract urothelial carcinomas by nephroureterectomy: state of the art review for the yearly scientific report of the French National Association of Urology].
Neuzillet Y; Colin P; Phé V; Shariat SF; Rouprêt M
Prog Urol; 2014 Nov; 24(15):1021-9. PubMed ID: 25158323
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
[TBL] [Abstract][Full Text] [Related]
57. [Prognostic factors of upper tract urothelial carcinoma].
Elalouf V; Klap J; Delongchamps NB; Conquy S; Sibony M; Saighi D; Peyromaure M; Flam T; Zerbib M; Xylinas E
Prog Urol; 2013 Dec; 23(16):1382-8. PubMed ID: 24274942
[TBL] [Abstract][Full Text] [Related]
58. Intravesical Therapy for Upper Urinary Tract Urothelial Carcinoma: A Comprehensive Review.
Wang Z; Shi H; Xu Y; Fang Y; Song J; Jiang W; Xia D; Wu Z; Wang L
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894387
[TBL] [Abstract][Full Text] [Related]
59. Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma.
Xylinas E; Kluth L; Mangal S; Roupret M; Karakiewicz PI; Shariat SF
World J Urol; 2013 Feb; 31(1):31-6. PubMed ID: 22986907
[TBL] [Abstract][Full Text] [Related]
60. Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma.
Seisen T; Shariat SF; Cussenot O; Peyronnet B; Renard-Penna R; Colin P; Rouprêt M
World J Urol; 2017 Apr; 35(4):535-548. PubMed ID: 26809456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
